EUPRAXIA PHARMACEUTICALS INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $0 for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-03-13
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|
| 2025-12-31 | $0.00 40-F · filed 2026-03-13 |
| 2024-12-31 | $1.20M 40-F · filed 2026-03-13 |
| 2023-12-31 | -$836.60K 40-F · filed 2025-03-20 |
| 2022-12-31 | -$1.06M 40-F · filed 2024-04-01 |